| Net Cash Provided by (Used in) Operating Activities |
-33.3M |
USD |
-117% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
4.97M |
USD |
-87.8% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-28.3M |
USD |
-211% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
79.4M |
USD |
-47.8% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
379K |
USD |
-47.6% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
8.33M |
USD |
+441% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
4.11M |
USD |
+237% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
94K |
USD |
+840% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1.1B |
USD |
+10.9% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
3.81M |
USD |
+376% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |